Dopamine D1-like Receptors Regulate Constitutive, μ-Opioid Receptor-Mediated Repression of Use-Dependent Synaptic Plasticity in Dorsal Horn Neurons: More Harm than Good?

The current study reports on a synaptic mechanism through which D1-like receptors (D1LRs) modulate spinal nociception and plasticity by regulating activation of the μ-opioid receptor (MOR).D1LR stimulation with agonist SKF 38393 concentration-dependently depressed C-fiber-evoked potentials in rats r...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of neuroscience Vol. 36; no. 20; pp. 5661 - 5673
Main Authors Aira, Zigor, Barrenetxea, Teresa, Buesa, Itsaso, García Del Caño, Gontzal, Azkue, Jon Jatsu
Format Journal Article
LanguageEnglish
Published United States Society for Neuroscience 18.05.2016
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The current study reports on a synaptic mechanism through which D1-like receptors (D1LRs) modulate spinal nociception and plasticity by regulating activation of the μ-opioid receptor (MOR).D1LR stimulation with agonist SKF 38393 concentration-dependently depressed C-fiber-evoked potentials in rats receiving spinal nerve ligation (SNL), but not in uninjured rats. Depression was prevented by MOR- but not GABA-receptor blockade. Neurons expressing the D1 subtype were immunopositive for met-enkephalin and vesicular glutamate transporter VGLUT2, but not for GABAergic marker vGAT.Nerve ligation was followed by increased immunoreactivity for D1 in synaptic compartment (P3) in dorsal horn homogenates and presynaptic met-enkephalin-containing boutons. SNL led to increased immunoreactivity for met-enkephalin in dorsal horn homogenates, which was dose-dependently attenuated by selective D1LR antagonist SCH 23390. During blockade of either D1R or MOR, low-frequency (0.2 or 3 Hz) stimulation (LFS) to the sciatic nerve induced long-term potentiation (LTP) of C-fiber-evoked potentials, revealing a constituent role of both receptors in repressing afferent-induced synaptic plasticity. LFS consistently induced NMDA receptor-dependent LTP in nerve-injured rats. The ability of MOR both to prevent LTP and to modulate mechanical and thermal pain thresholds in behavioral tests was preserved in nerve-ligated rats that were postoperatively treated with SCH 23390. D1LR priming for 30 min sufficed to disrupt MOR function in otherwise naive rats via a mechanism involving receptor overuse.The current data support that, whereas D1LR-modulated MOR activation is instrumental in antinociception and endogenous repression of synaptic plasticity, this mechanism deteriorates rapidly by sustained use, generating increased vulnerability to afferent input. The current study shows that dopamine D1-like receptors (D1LRs) and μ-opioid receptors (MOR) in the spinal dorsal horn constitutively repress the expression of synaptic long-term potentiation (LTP) of C-fiber-evoked potentials. Anatomical data are provided supporting that the D1 subtype regulates MOR function by modulating met-enkephalin release. Sustained neuropathic pain induced by spinal nerve ligation is accompanied by D1R and met-enkephalin upregulation, acquired D1LR-mediated antinociception, and a loss of endogenous repression of further synaptic plasticity. We show that the ability of MOR to oppose LTP is rapidly impaired by sustained D1LR activation via a mechanism involving sustained MOR activation.
AbstractList UNLABELLEDThe current study reports on a synaptic mechanism through which D1-like receptors (D1LRs) modulate spinal nociception and plasticity by regulating activation of the μ-opioid receptor (MOR).D1LR stimulation with agonist SKF 38393 concentration-dependently depressed C-fiber-evoked potentials in rats receiving spinal nerve ligation (SNL), but not in uninjured rats. Depression was prevented by MOR- but not GABA-receptor blockade. Neurons expressing the D1 subtype were immunopositive for met-enkephalin and vesicular glutamate transporter VGLUT2, but not for GABAergic marker vGAT.Nerve ligation was followed by increased immunoreactivity for D1 in synaptic compartment (P3) in dorsal horn homogenates and presynaptic met-enkephalin-containing boutons. SNL led to increased immunoreactivity for met-enkephalin in dorsal horn homogenates, which was dose-dependently attenuated by selective D1LR antagonist SCH 23390. During blockade of either D1R or MOR, low-frequency (0.2 or 3 Hz) stimulation (LFS) to the sciatic nerve induced long-term potentiation (LTP) of C-fiber-evoked potentials, revealing a constituent role of both receptors in repressing afferent-induced synaptic plasticity. LFS consistently induced NMDA receptor-dependent LTP in nerve-injured rats. The ability of MOR both to prevent LTP and to modulate mechanical and thermal pain thresholds in behavioral tests was preserved in nerve-ligated rats that were postoperatively treated with SCH 23390. D1LR priming for 30 min sufficed to disrupt MOR function in otherwise naive rats via a mechanism involving receptor overuse.The current data support that, whereas D1LR-modulated MOR activation is instrumental in antinociception and endogenous repression of synaptic plasticity, this mechanism deteriorates rapidly by sustained use, generating increased vulnerability to afferent input.SIGNIFICANCE STATEMENTThe current study shows that dopamine D1-like receptors (D1LRs) and μ-opioid receptors (MOR) in the spinal dorsal horn constitutively repress the expression of synaptic long-term potentiation (LTP) of C-fiber-evoked potentials. Anatomical data are provided supporting that the D1 subtype regulates MOR function by modulating met-enkephalin release. Sustained neuropathic pain induced by spinal nerve ligation is accompanied by D1R and met-enkephalin upregulation, acquired D1LR-mediated antinociception, and a loss of endogenous repression of further synaptic plasticity. We show that the ability of MOR to oppose LTP is rapidly impaired by sustained D1LR activation via a mechanism involving sustained MOR activation.
The current study reports on a synaptic mechanism through which D1-like receptors (D1LRs) modulate spinal nociception and plasticity by regulating activation of the μ-opioid receptor (MOR). D1LR stimulation with agonist SKF 38393 concentration-dependently depressed C-fiber-evoked potentials in rats receiving spinal nerve ligation (SNL), but not in uninjured rats. Depression was prevented by MOR- but not GABA-receptor blockade. Neurons expressing the D1 subtype were immunopositive for met-enkephalin and vesicular glutamate transporter VGLUT2, but not for GABAergic marker vGAT. Nerve ligation was followed by increased immunoreactivity for D1 in synaptic compartment (P3) in dorsal horn homogenates and presynaptic met-enkephalin-containing boutons. SNL led to increased immunoreactivity for met-enkephalin in dorsal horn homogenates, which was dose-dependently attenuated by selective D1LR antagonist SCH 23390. During blockade of either D1R or MOR, low-frequency (0.2 or 3 Hz) stimulation (LFS) to the sciatic nerve induced long-term potentiation (LTP) of C-fiber-evoked potentials, revealing a constituent role of both receptors in repressing afferent-induced synaptic plasticity. LFS consistently induced NMDA receptor-dependent LTP in nerve-injured rats. The ability of MOR both to prevent LTP and to modulate mechanical and thermal pain thresholds in behavioral tests was preserved in nerve-ligated rats that were postoperatively treated with SCH 23390. D1LR priming for 30 min sufficed to disrupt MOR function in otherwise naive rats via a mechanism involving receptor overuse. The current data support that, whereas D1LR-modulated MOR activation is instrumental in antinociception and endogenous repression of synaptic plasticity, this mechanism deteriorates rapidly by sustained use, generating increased vulnerability to afferent input. SIGNIFICANCE STATEMENT The current study shows that dopamine D1-like receptors (D1LRs) and μ-opioid receptors (MOR) in the spinal dorsal horn constitutively repress the expression of synaptic long-term potentiation (LTP) of C-fiber-evoked potentials. Anatomical data are provided supporting that the D1 subtype regulates MOR function by modulating met-enkephalin release. Sustained neuropathic pain induced by spinal nerve ligation is accompanied by D1R and met-enkephalin upregulation, acquired D1LR-mediated antinociception, and a loss of endogenous repression of further synaptic plasticity. We show that the ability of MOR to oppose LTP is rapidly impaired by sustained D1LR activation via a mechanism involving sustained MOR activation.
The current study reports on a synaptic mechanism through which D1-like receptors (D1LRs) modulate spinal nociception and plasticity by regulating activation of the μ-opioid receptor (MOR).D1LR stimulation with agonist SKF 38393 concentration-dependently depressed C-fiber-evoked potentials in rats receiving spinal nerve ligation (SNL), but not in uninjured rats. Depression was prevented by MOR- but not GABA-receptor blockade. Neurons expressing the D1 subtype were immunopositive for met-enkephalin and vesicular glutamate transporter VGLUT2, but not for GABAergic marker vGAT.Nerve ligation was followed by increased immunoreactivity for D1 in synaptic compartment (P3) in dorsal horn homogenates and presynaptic met-enkephalin-containing boutons. SNL led to increased immunoreactivity for met-enkephalin in dorsal horn homogenates, which was dose-dependently attenuated by selective D1LR antagonist SCH 23390. During blockade of either D1R or MOR, low-frequency (0.2 or 3 Hz) stimulation (LFS) to the sciatic nerve induced long-term potentiation (LTP) of C-fiber-evoked potentials, revealing a constituent role of both receptors in repressing afferent-induced synaptic plasticity. LFS consistently induced NMDA receptor-dependent LTP in nerve-injured rats. The ability of MOR both to prevent LTP and to modulate mechanical and thermal pain thresholds in behavioral tests was preserved in nerve-ligated rats that were postoperatively treated with SCH 23390. D1LR priming for 30 min sufficed to disrupt MOR function in otherwise naive rats via a mechanism involving receptor overuse.The current data support that, whereas D1LR-modulated MOR activation is instrumental in antinociception and endogenous repression of synaptic plasticity, this mechanism deteriorates rapidly by sustained use, generating increased vulnerability to afferent input. The current study shows that dopamine D1-like receptors (D1LRs) and μ-opioid receptors (MOR) in the spinal dorsal horn constitutively repress the expression of synaptic long-term potentiation (LTP) of C-fiber-evoked potentials. Anatomical data are provided supporting that the D1 subtype regulates MOR function by modulating met-enkephalin release. Sustained neuropathic pain induced by spinal nerve ligation is accompanied by D1R and met-enkephalin upregulation, acquired D1LR-mediated antinociception, and a loss of endogenous repression of further synaptic plasticity. We show that the ability of MOR to oppose LTP is rapidly impaired by sustained D1LR activation via a mechanism involving sustained MOR activation.
Author Buesa, Itsaso
García Del Caño, Gontzal
Azkue, Jon Jatsu
Barrenetxea, Teresa
Aira, Zigor
Author_xml – sequence: 1
  givenname: Zigor
  orcidid: 0000-0001-6307-0565
  surname: Aira
  fullname: Aira, Zigor
  organization: Department of Neurosciences, School of Medicine and Dentistry, University of the Basque Country UPV/EHU, 48940 Leioa, Bizkaia, Spain, and
– sequence: 2
  givenname: Teresa
  surname: Barrenetxea
  fullname: Barrenetxea, Teresa
  organization: Department of Neurosciences, School of Medicine and Dentistry, University of the Basque Country UPV/EHU, 48940 Leioa, Bizkaia, Spain, and
– sequence: 3
  givenname: Itsaso
  orcidid: 0000-0002-8609-5500
  surname: Buesa
  fullname: Buesa, Itsaso
  organization: Department of Neurosciences, School of Medicine and Dentistry, University of the Basque Country UPV/EHU, 48940 Leioa, Bizkaia, Spain, and
– sequence: 4
  givenname: Gontzal
  orcidid: 0000-0002-7098-0986
  surname: García Del Caño
  fullname: García Del Caño, Gontzal
  organization: Department of Neurosciences, Faculty of Pharmacy, University of the Basque Country UPV/EHU, 01080 Vitoria-Gasteiz, Araba, Spain
– sequence: 5
  givenname: Jon Jatsu
  orcidid: 0000-0002-8609-5500
  surname: Azkue
  fullname: Azkue, Jon Jatsu
  email: jonjatsu.azkue@ehu.eus
  organization: Department of Neurosciences, School of Medicine and Dentistry, University of the Basque Country UPV/EHU, 48940 Leioa, Bizkaia, Spain, and jonjatsu.azkue@ehu.eus
BackLink https://www.ncbi.nlm.nih.gov/pubmed/27194343$$D View this record in MEDLINE/PubMed
BookMark eNpVkcFu1DAQhi1URLeFV6h85IC3duLECQcQ2i3doraLWvZsOc6kNWTtYDuV9pV4hj4Dz4SjlhUcLFsz__z_yN8ROrDOAkInjM5ZkeWnX67PNjfr28XFPONlTVgxzygrX6BZ6tYk45QdoBnNBCUlF_wQHYXwnVIqKBOv0GEmWM1zns_Qr6Ub1NZYwEtGevMD8A1oGKLzIb3uxl5FwAtnQzRxjOYB3uHfj2Q9GGfavZRcQWuScKoMHkIwzmLX4U0AsoQBbAs24tudVUM0Gn_tVbLTJu6wsXiZolSPV85bfA2jT1nv8ZXzgFfKb3G8VxafO9d-fI1edqoP8Ob5Pkabz2ffFityuT6_WHy6JJozHgl0lS4UZ-V0hKBlmTWs0VrXoCtGu6JueFFUWouC865tWaVyqLNKUKibqhb5Mfrw5DuMzRZanXb3qpeDN1vld9IpI__vWHMv79yDLMv0u2WdDN4-G3j3c4QQ5dYEDX2vLLgxSCZqyos8pzxJyyep9i4ED90-hlE5gZZ70HICnWpyAp0GT_5dcj_2l2z-BzUWq2Y
CitedBy_id crossref_primary_10_1016_j_bja_2019_07_028
crossref_primary_10_1371_journal_pone_0162416
crossref_primary_10_1523_JNEUROSCI_2110_17_2017
crossref_primary_10_1097_PR9_0000000000000923
crossref_primary_10_3389_fnana_2023_1111008
crossref_primary_10_1016_j_brainres_2022_148167
crossref_primary_10_1007_s00213_019_05275_3
crossref_primary_10_1093_ptj_pzaa223
crossref_primary_10_1016_j_ejphar_2023_175696
crossref_primary_10_1097_j_pain_0000000000001400
crossref_primary_10_15252_embr_202256098
crossref_primary_10_3390_ijms21061945
crossref_primary_10_1016_j_neuroscience_2019_03_034
crossref_primary_10_1155_2017_8109205
crossref_primary_10_1016_j_ejphar_2019_03_020
crossref_primary_10_1371_journal_pone_0294100
crossref_primary_10_1007_s12640_020_00313_x
crossref_primary_10_1016_j_peptides_2018_01_011
Cites_doi 10.1016/0304-3959(92)90041-9
10.1186/1744-8069-3-9
10.1081/RRS-200029981
10.1016/j.coph.2011.10.018
10.1016/0165-0270(94)00176-H
10.1038/366344a0
10.1016/j.jneumeth.2008.05.003
10.1046/j.1460-9568.2003.02406.x
10.1126/science.288.5472.1765
10.1038/bjp.2008.100
10.1111/j.1471-4159.2010.06715.x
10.1016/S0006-8993(98)00332-1
10.1113/jphysiol.1988.sp017084
10.1111/j.1748-1716.1979.tb06491.x
10.1523/JNEUROSCI.5552-03.2004
10.1016/j.pain.2010.09.034
10.1002/jnr.21207
10.1016/j.pain.2011.03.030
10.1016/j.neuropharm.2008.08.029
10.1002/cne.903500307
10.1016/j.neuroscience.2007.07.052
10.1016/S0304-3940(01)01692-5
10.1016/j.pain.2003.08.007
10.1016/j.expneurol.2008.04.034
10.1016/0304-3940(92)90206-M
10.1016/0306-4522(86)90010-2
10.1016/j.jpain.2009.06.012
10.1523/JNEUROSCI.22-12-05129.2002
10.1113/jphysiol.2005.091843
10.1046/j.1526-4610.2001.111006303.x
10.1523/JNEUROSCI.2887-09.2009
10.1016/0306-4522(94)90315-8
10.1016/0304-3940(95)11553-0
10.1016/j.ejphar.2007.07.062
10.1523/JNEUROSCI.0346-04.2004
10.1111/j.1748-1716.2007.01756.x
10.1152/jn.01324.2004
10.1016/j.pain.2012.03.017
10.1007/BF00294809
10.3389/fncir.2014.00062
10.1016/S0896-6273(00)80210-X
10.1016/j.brainres.2013.10.044
10.1371/journal.pone.0013306
10.1016/S0304-3959(00)00290-6
10.1523/JNEUROSCI.13-12-05228.1993
10.1016/j.pain.2014.09.012
10.1002/cne.22130
10.1016/0306-4522(96)00333-8
10.1124/pr.110.002642
10.1111/j.1749-6632.2001.tb05823.x
10.1016/j.neuropharm.2005.11.005
10.1016/0006-8993(85)91134-5
10.1016/j.neuropharm.2011.01.034
10.1097/AJP.0b013e31816b2f43
10.1523/JNEUROSCI.0960-06.2006
10.1016/0092-8674(94)90557-6
10.1007/s11916-009-0048-3
10.1124/pr.112.005942
10.1016/0165-0270(94)90144-9
10.1038/sj.bjp.0705234
10.1002/(SICI)1098-2396(199712)27:4<313::AID-SYN5>3.0.CO;2-F
10.1523/JNEUROSCI.20-09-03496.2000
10.1002/ana.20296
10.1523/JNEUROSCI.15-12-08156.1995
10.1097/00001756-199804200-00041
10.1186/1744-8069-4-41
10.1016/j.brainres.2014.11.009
10.1016/S0306-3623(98)00250-X
10.1007/s00221-005-0075-1
10.1016/S0306-4522(97)00272-8
10.1016/j.neuropharm.2013.08.010
10.1002/cne.903450104
10.1038/nrn1431
10.1002/cne.903440109
10.1016/j.jpain.2008.10.003
10.1016/j.tins.2003.09.017
10.1016/j.neuron.2012.09.023
10.1016/S0361-9230(00)00460-3
10.1152/jn.2001.85.2.485
10.1016/j.ab.2010.02.036
10.1016/0891-0618(95)00055-C
10.1523/JNEUROSCI.17-22-08687.1997
10.1073/pnas.0502418102
10.1016/j.pain.2013.06.009
10.1016/j.pain.2010.02.011
10.1016/j.pain.2009.04.005
10.1016/S0165-0173(99)00020-X
10.1523/JNEUROSCI.15-05-03328.1995
10.1111/j.1460-9568.1996.tb01247.x
10.1016/j.expneurol.2008.10.018
10.1523/JNEUROSCI.3481-14.2015
10.1111/j.1749-6632.2000.tb06673.x
10.1007/s002100100404
10.1016/j.neuroscience.2007.05.036
ContentType Journal Article
Copyright Copyright © 2016 the authors 0270-6474/16/365662-13$15.00/0.
Copyright © 2016 the authors 0270-6474/16/365662-13$15.00/0 2016
Copyright_xml – notice: Copyright © 2016 the authors 0270-6474/16/365662-13$15.00/0.
– notice: Copyright © 2016 the authors 0270-6474/16/365662-13$15.00/0 2016
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
5PM
DOI 10.1523/JNEUROSCI.2469-15.2016
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
CrossRef

MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
EISSN 1529-2401
EndPage 5673
ExternalDocumentID 10_1523_JNEUROSCI_2469_15_2016
27194343
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
-DZ
-~X
.55
18M
2WC
34G
39C
53G
5GY
5RE
5VS
AAFWJ
ABBAR
ABIVO
ACGUR
ACNCT
ADBBV
ADCOW
AENEX
AFCFT
AFHIN
AFOSN
AHWXS
AIZTS
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BTFSW
CGR
CS3
CUY
CVF
DIK
DU5
E3Z
EBS
ECM
EIF
EJD
F5P
GX1
H13
HYE
H~9
KQ8
L7B
NPM
OK1
P0W
P2P
QZG
R.V
RHF
RHI
RPM
TFN
TR2
W8F
WH7
WOQ
X7M
XJT
YBU
YHG
YKV
YNH
YSK
AAYXX
CITATION
7X8
5PM
ID FETCH-LOGICAL-c414t-ef8c5a416a416770662b1bccc9ec810f59b4558cc7544fdd18a3e92870e9b8973
IEDL.DBID RPM
ISSN 0270-6474
IngestDate Tue Sep 17 21:26:44 EDT 2024
Fri Oct 25 02:13:46 EDT 2024
Fri Aug 23 02:33:55 EDT 2024
Sat Sep 28 08:37:27 EDT 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 20
Keywords LTP
immunocytochemistry
nociception
spinal cord
electrophysiology
nerve injury
Language English
License Copyright © 2016 the authors 0270-6474/16/365662-13$15.00/0.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c414t-ef8c5a416a416770662b1bccc9ec810f59b4558cc7544fdd18a3e92870e9b8973
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Author contributions: Z.A. and J.J.A. designed research; Z.A., T.B., I.B., and G.G.d.C. performed research; Z.A., T.B., I.B., and G.G.d.C. analyzed data; Z.A. and J.J.A. wrote the paper.
ORCID 0000-0001-6307-0565
0000-0002-8609-5500
0000-0002-7098-0986
OpenAccessLink https://www.jneurosci.org/content/jneuro/36/20/5661.full.pdf
PMID 27194343
PQID 1790453304
PQPubID 23479
PageCount 13
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_6601769
proquest_miscellaneous_1790453304
crossref_primary_10_1523_JNEUROSCI_2469_15_2016
pubmed_primary_27194343
PublicationCentury 2000
PublicationDate 2016-05-18
20160518
PublicationDateYYYYMMDD 2016-05-18
PublicationDate_xml – month: 05
  year: 2016
  text: 2016-05-18
  day: 18
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle The Journal of neuroscience
PublicationTitleAlternate J Neurosci
PublicationYear 2016
Publisher Society for Neuroscience
Publisher_xml – name: Society for Neuroscience
References 2023041803191475000_36.20.5661.90
Arvidsson (2023041803191475000_36.20.5661.8) 1995; 15
2023041803191475000_36.20.5661.41
2023041803191475000_36.20.5661.85
2023041803191475000_36.20.5661.84
2023041803191475000_36.20.5661.43
Terman (2023041803191475000_36.20.5661.78) 2001; 85
2023041803191475000_36.20.5661.87
Ji (2023041803191475000_36.20.5661.40) 1995; 15
2023041803191475000_36.20.5661.42
2023041803191475000_36.20.5661.86
2023041803191475000_36.20.5661.81
2023041803191475000_36.20.5661.80
2023041803191475000_36.20.5661.83
2023041803191475000_36.20.5661.82
2023041803191475000_36.20.5661.49
2023041803191475000_36.20.5661.48
2023041803191475000_36.20.5661.45
2023041803191475000_36.20.5661.89
2023041803191475000_36.20.5661.44
2023041803191475000_36.20.5661.88
2023041803191475000_36.20.5661.47
2023041803191475000_36.20.5661.46
2023041803191475000_36.20.5661.9
2023041803191475000_36.20.5661.30
2023041803191475000_36.20.5661.74
2023041803191475000_36.20.5661.73
2023041803191475000_36.20.5661.32
2023041803191475000_36.20.5661.76
2023041803191475000_36.20.5661.31
2023041803191475000_36.20.5661.75
2023041803191475000_36.20.5661.70
2023041803191475000_36.20.5661.71
2023041803191475000_36.20.5661.3
2023041803191475000_36.20.5661.38
2023041803191475000_36.20.5661.2
2023041803191475000_36.20.5661.37
2023041803191475000_36.20.5661.1
Schoffelmeer (2023041803191475000_36.20.5661.72) 2000; 20
2023041803191475000_36.20.5661.39
2023041803191475000_36.20.5661.7
2023041803191475000_36.20.5661.34
2023041803191475000_36.20.5661.6
2023041803191475000_36.20.5661.33
2023041803191475000_36.20.5661.77
2023041803191475000_36.20.5661.5
2023041803191475000_36.20.5661.36
2023041803191475000_36.20.5661.4
2023041803191475000_36.20.5661.35
2023041803191475000_36.20.5661.79
Raynor (2023041803191475000_36.20.5661.67) 1994; 45
2023041803191475000_36.20.5661.63
2023041803191475000_36.20.5661.62
2023041803191475000_36.20.5661.21
2023041803191475000_36.20.5661.65
2023041803191475000_36.20.5661.64
2023041803191475000_36.20.5661.61
2023041803191475000_36.20.5661.60
2023041803191475000_36.20.5661.27
2023041803191475000_36.20.5661.29
2023041803191475000_36.20.5661.28
2023041803191475000_36.20.5661.23
2023041803191475000_36.20.5661.22
2023041803191475000_36.20.5661.25
2023041803191475000_36.20.5661.69
2023041803191475000_36.20.5661.24
2023041803191475000_36.20.5661.68
2023041803191475000_36.20.5661.19
Burgess (2023041803191475000_36.20.5661.20) 2002; 22
Chen (2023041803191475000_36.20.5661.26) 1997; 17
2023041803191475000_36.20.5661.52
2023041803191475000_36.20.5661.51
2023041803191475000_36.20.5661.10
2023041803191475000_36.20.5661.54
2023041803191475000_36.20.5661.95
2023041803191475000_36.20.5661.53
2023041803191475000_36.20.5661.93
Randić (2023041803191475000_36.20.5661.66) 1993; 13
2023041803191475000_36.20.5661.94
2023041803191475000_36.20.5661.50
2023041803191475000_36.20.5661.91
2023041803191475000_36.20.5661.92
2023041803191475000_36.20.5661.16
2023041803191475000_36.20.5661.15
2023041803191475000_36.20.5661.59
2023041803191475000_36.20.5661.18
2023041803191475000_36.20.5661.17
2023041803191475000_36.20.5661.12
2023041803191475000_36.20.5661.56
2023041803191475000_36.20.5661.11
2023041803191475000_36.20.5661.55
2023041803191475000_36.20.5661.14
2023041803191475000_36.20.5661.58
2023041803191475000_36.20.5661.13
2023041803191475000_36.20.5661.57
References_xml – volume: 45
  start-page: 330
  year: 1994
  ident: 2023041803191475000_36.20.5661.67
  article-title: Pharmacological characterization of the cloned kappa-, delta-, and mu-opioid receptors
  publication-title: Mol Pharmacol
  contributor:
    fullname: Raynor
– ident: 2023041803191475000_36.20.5661.45
  doi: 10.1016/0304-3959(92)90041-9
– ident: 2023041803191475000_36.20.5661.69
  doi: 10.1186/1744-8069-3-9
– ident: 2023041803191475000_36.20.5661.61
  doi: 10.1081/RRS-200029981
– ident: 2023041803191475000_36.20.5661.70
  doi: 10.1016/j.coph.2011.10.018
– ident: 2023041803191475000_36.20.5661.14
  doi: 10.1016/0165-0270(94)00176-H
– ident: 2023041803191475000_36.20.5661.22
  doi: 10.1038/366344a0
– ident: 2023041803191475000_36.20.5661.5
  doi: 10.1016/j.jneumeth.2008.05.003
– ident: 2023041803191475000_36.20.5661.80
  doi: 10.1046/j.1460-9568.2003.02406.x
– ident: 2023041803191475000_36.20.5661.86
  doi: 10.1126/science.288.5472.1765
– ident: 2023041803191475000_36.20.5661.28
  doi: 10.1038/bjp.2008.100
– ident: 2023041803191475000_36.20.5661.39
  doi: 10.1111/j.1471-4159.2010.06715.x
– ident: 2023041803191475000_36.20.5661.50
  doi: 10.1016/S0006-8993(98)00332-1
– ident: 2023041803191475000_36.20.5661.33
  doi: 10.1113/jphysiol.1988.sp017084
– ident: 2023041803191475000_36.20.5661.37
  doi: 10.1111/j.1748-1716.1979.tb06491.x
– ident: 2023041803191475000_36.20.5661.88
  doi: 10.1523/JNEUROSCI.5552-03.2004
– ident: 2023041803191475000_36.20.5661.77
  doi: 10.1016/j.pain.2010.09.034
– ident: 2023041803191475000_36.20.5661.93
  doi: 10.1002/jnr.21207
– ident: 2023041803191475000_36.20.5661.47
  doi: 10.1016/j.pain.2011.03.030
– ident: 2023041803191475000_36.20.5661.19
  doi: 10.1016/j.neuropharm.2008.08.029
– ident: 2023041803191475000_36.20.5661.54
  doi: 10.1002/cne.903500307
– ident: 2023041803191475000_36.20.5661.95
  doi: 10.1016/j.neuroscience.2007.07.052
– ident: 2023041803191475000_36.20.5661.49
  doi: 10.1016/S0304-3940(01)01692-5
– ident: 2023041803191475000_36.20.5661.10
  doi: 10.1016/j.pain.2003.08.007
– ident: 2023041803191475000_36.20.5661.94
  doi: 10.1016/j.expneurol.2008.04.034
– ident: 2023041803191475000_36.20.5661.79
  doi: 10.1016/0304-3940(92)90206-M
– ident: 2023041803191475000_36.20.5661.31
  doi: 10.1016/0306-4522(86)90010-2
– ident: 2023041803191475000_36.20.5661.48
  doi: 10.1016/j.jpain.2009.06.012
– volume: 22
  start-page: 5129
  year: 2002
  ident: 2023041803191475000_36.20.5661.20
  article-title: Time-dependent descending facilitation from the rostral ventromedial medulla maintains, but does not initiate, neuropathic pain
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.22-12-05129.2002
  contributor:
    fullname: Burgess
– ident: 2023041803191475000_36.20.5661.76
  doi: 10.1113/jphysiol.2005.091843
– ident: 2023041803191475000_36.20.5661.84
  doi: 10.1046/j.1526-4610.2001.111006303.x
– ident: 2023041803191475000_36.20.5661.25
  doi: 10.1523/JNEUROSCI.2887-09.2009
– ident: 2023041803191475000_36.20.5661.71
  doi: 10.1016/0306-4522(94)90315-8
– ident: 2023041803191475000_36.20.5661.52
  doi: 10.1016/0304-3940(95)11553-0
– ident: 2023041803191475000_36.20.5661.60
  doi: 10.1016/j.ejphar.2007.07.062
– ident: 2023041803191475000_36.20.5661.51
  doi: 10.1523/JNEUROSCI.0346-04.2004
– ident: 2023041803191475000_36.20.5661.63
  doi: 10.1111/j.1748-1716.2007.01756.x
– ident: 2023041803191475000_36.20.5661.89
  doi: 10.1152/jn.01324.2004
– ident: 2023041803191475000_36.20.5661.1
  doi: 10.1016/j.pain.2012.03.017
– ident: 2023041803191475000_36.20.5661.74
  doi: 10.1007/BF00294809
– ident: 2023041803191475000_36.20.5661.17
  doi: 10.3389/fncir.2014.00062
– ident: 2023041803191475000_36.20.5661.82
  doi: 10.1016/S0896-6273(00)80210-X
– ident: 2023041803191475000_36.20.5661.38
  doi: 10.1016/j.brainres.2013.10.044
– ident: 2023041803191475000_36.20.5661.11
  doi: 10.1371/journal.pone.0013306
– ident: 2023041803191475000_36.20.5661.46
  doi: 10.1016/S0304-3959(00)00290-6
– volume: 13
  start-page: 5228
  year: 1993
  ident: 2023041803191475000_36.20.5661.66
  article-title: Long-term potentiation and long-term depression of primary afferent neurotransmission in the rat spinal cord
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.13-12-05228.1993
  contributor:
    fullname: Randić
– ident: 2023041803191475000_36.20.5661.3
  doi: 10.1016/j.pain.2014.09.012
– ident: 2023041803191475000_36.20.5661.59
  doi: 10.1002/cne.22130
– ident: 2023041803191475000_36.20.5661.43
  doi: 10.1016/0306-4522(96)00333-8
– ident: 2023041803191475000_36.20.5661.13
  doi: 10.1124/pr.110.002642
– ident: 2023041803191475000_36.20.5661.57
  doi: 10.1111/j.1749-6632.2001.tb05823.x
– ident: 2023041803191475000_36.20.5661.18
  doi: 10.1016/j.neuropharm.2005.11.005
– ident: 2023041803191475000_36.20.5661.73
  doi: 10.1016/0006-8993(85)91134-5
– ident: 2023041803191475000_36.20.5661.23
  doi: 10.1016/j.neuropharm.2011.01.034
– ident: 2023041803191475000_36.20.5661.29
  doi: 10.1097/AJP.0b013e31816b2f43
– ident: 2023041803191475000_36.20.5661.35
  doi: 10.1523/JNEUROSCI.0960-06.2006
– ident: 2023041803191475000_36.20.5661.87
  doi: 10.1016/0092-8674(94)90557-6
– ident: 2023041803191475000_36.20.5661.16
  doi: 10.1007/s11916-009-0048-3
– ident: 2023041803191475000_36.20.5661.85
  doi: 10.1124/pr.112.005942
– ident: 2023041803191475000_36.20.5661.24
  doi: 10.1016/0165-0270(94)90144-9
– ident: 2023041803191475000_36.20.5661.6
  doi: 10.1038/sj.bjp.0705234
– ident: 2023041803191475000_36.20.5661.7
  doi: 10.1002/(SICI)1098-2396(199712)27:4<313::AID-SYN5>3.0.CO;2-F
– volume: 20
  start-page: 3496
  year: 2000
  ident: 2023041803191475000_36.20.5661.72
  article-title: Synergistically interacting dopamine D1 and NMDA receptors mediate nonvesicular transporter-dependent GABA release from rat striatal medium spiny neurons
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.20-09-03496.2000
  contributor:
    fullname: Schoffelmeer
– ident: 2023041803191475000_36.20.5661.9
  doi: 10.1002/ana.20296
– volume: 15
  start-page: 8156
  year: 1995
  ident: 2023041803191475000_36.20.5661.40
  article-title: Expression of μ-, δ-, and κ-opioid receptor-like immunoreactivities in rat dorsal root ganglia after carrageenan-induced inflammation
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.15-12-08156.1995
  contributor:
    fullname: Ji
– ident: 2023041803191475000_36.20.5661.75
  doi: 10.1097/00001756-199804200-00041
– ident: 2023041803191475000_36.20.5661.27
  doi: 10.1186/1744-8069-4-41
– ident: 2023041803191475000_36.20.5661.4
  doi: 10.1016/j.brainres.2014.11.009
– ident: 2023041803191475000_36.20.5661.92
  doi: 10.1016/S0306-3623(98)00250-X
– ident: 2023041803191475000_36.20.5661.64
  doi: 10.1007/s00221-005-0075-1
– ident: 2023041803191475000_36.20.5661.21
  doi: 10.1016/S0306-4522(97)00272-8
– ident: 2023041803191475000_36.20.5661.53
  doi: 10.1016/j.neuropharm.2013.08.010
– ident: 2023041803191475000_36.20.5661.30
  doi: 10.1002/cne.903450104
– ident: 2023041803191475000_36.20.5661.32
  doi: 10.1038/nrn1431
– ident: 2023041803191475000_36.20.5661.91
  doi: 10.1002/cne.903440109
– ident: 2023041803191475000_36.20.5661.36
  doi: 10.1016/j.jpain.2008.10.003
– ident: 2023041803191475000_36.20.5661.41
  doi: 10.1016/j.tins.2003.09.017
– ident: 2023041803191475000_36.20.5661.81
  doi: 10.1016/j.neuron.2012.09.023
– ident: 2023041803191475000_36.20.5661.34
  doi: 10.1016/S0361-9230(00)00460-3
– volume: 85
  start-page: 485
  year: 2001
  ident: 2023041803191475000_36.20.5661.78
  article-title: Mu opiates inhibit long-term potentiation induction in the spinal cord slice
  publication-title: J Neurophysiol
  doi: 10.1152/jn.2001.85.2.485
  contributor:
    fullname: Terman
– ident: 2023041803191475000_36.20.5661.68
  doi: 10.1016/j.ab.2010.02.036
– ident: 2023041803191475000_36.20.5661.55
  doi: 10.1016/0891-0618(95)00055-C
– volume: 17
  start-page: 8687
  year: 1997
  ident: 2023041803191475000_36.20.5661.26
  article-title: The mechanism of cAMP-mediated enhancement at a cerebellar synapse
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.17-22-08687.1997
  contributor:
    fullname: Chen
– ident: 2023041803191475000_36.20.5661.12
  doi: 10.1073/pnas.0502418102
– ident: 2023041803191475000_36.20.5661.2
  doi: 10.1016/j.pain.2013.06.009
– ident: 2023041803191475000_36.20.5661.42
  doi: 10.1016/j.pain.2010.02.011
– ident: 2023041803191475000_36.20.5661.90
  doi: 10.1016/j.pain.2009.04.005
– ident: 2023041803191475000_36.20.5661.56
  doi: 10.1016/S0165-0173(99)00020-X
– volume: 15
  start-page: 3328
  year: 1995
  ident: 2023041803191475000_36.20.5661.8
  article-title: Distribution and targeting of a μ-opioid receptor (MOR1) in brain and spinal cord
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.15-05-03328.1995
  contributor:
    fullname: Arvidsson
– ident: 2023041803191475000_36.20.5661.83
  doi: 10.1111/j.1460-9568.1996.tb01247.x
– ident: 2023041803191475000_36.20.5661.65
  doi: 10.1016/j.expneurol.2008.10.018
– ident: 2023041803191475000_36.20.5661.44
  doi: 10.1523/JNEUROSCI.3481-14.2015
– ident: 2023041803191475000_36.20.5661.62
  doi: 10.1111/j.1749-6632.2000.tb06673.x
– ident: 2023041803191475000_36.20.5661.15
  doi: 10.1007/s002100100404
– ident: 2023041803191475000_36.20.5661.58
  doi: 10.1016/j.neuroscience.2007.05.036
SSID ssj0007017
Score 2.3497677
Snippet The current study reports on a synaptic mechanism through which D1-like receptors (D1LRs) modulate spinal nociception and plasticity by regulating activation...
UNLABELLEDThe current study reports on a synaptic mechanism through which D1-like receptors (D1LRs) modulate spinal nociception and plasticity by regulating...
SourceID pubmedcentral
proquest
crossref
pubmed
SourceType Open Access Repository
Aggregation Database
Index Database
StartPage 5661
SubjectTerms 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine - pharmacology
Animals
Benzazepines - pharmacology
Dopamine Agonists - pharmacology
Dopamine Antagonists - pharmacology
Evoked Potentials
Glucose Transporter Type 2 - metabolism
HEK293 Cells
Humans
Long-Term Potentiation
Male
Nociception
Pain Threshold
Posterior Horn Cells - metabolism
Posterior Horn Cells - physiology
Rats
Rats, Sprague-Dawley
Receptors, Dopamine D1 - agonists
Receptors, Dopamine D1 - antagonists & inhibitors
Receptors, Dopamine D1 - metabolism
Receptors, GABA - metabolism
Receptors, Opioid, mu - metabolism
Title Dopamine D1-like Receptors Regulate Constitutive, μ-Opioid Receptor-Mediated Repression of Use-Dependent Synaptic Plasticity in Dorsal Horn Neurons: More Harm than Good?
URI https://www.ncbi.nlm.nih.gov/pubmed/27194343
https://search.proquest.com/docview/1790453304
https://pubmed.ncbi.nlm.nih.gov/PMC6601769
Volume 36
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3LbtNAFB01XbFBlPIIlOoiIVZMHNszfrBBVUIJRSlFJVJ31ng8Fhb1OErcRX6Jb-Ab-CbundgRgR0LS5afI93rmXNmjs9l7FUQIagvRcDDoJBcSKV4iqMQN2FUkP1WahSt6M4vo9lCXNzImwMm-39hnGhf59XI3tYjW31z2splrb1eJ-ZdzScRsog4Sr0BG2CC9hS9637jsSuzi3QLeZGIRfdbMBIu7-KS5HHXk4-jAFkh9yVJu6iIURD75JMW7g9O_yDOv4WTf4xE5w_Y_Q5Cwtm2qUfswNiH7PjMIn2uN_AanKjTzZYfsx9TJMU1IkmY-vy2-m4AcaJZUokd3HNl6A1Q0U6nGMCe7w38-sk_L6umKnaX8rmr52HoSKebtdCUsFgbPu2K6LZwvbEK-x8NVwjISavdbqCyMMVXYWtnzcqCcwKx67cwb1YGZmpVA83cw4emKd49Yovz918nM96VZ-Ba-KLlpky0VAjoaItjspLP_VxrnRqd-ONSprmQMtGaPPbKovATFZqUFlZNmidpHD5mh7ax5imDcVRKFSd5WSI-K8a5QhSkSpUg_IpkqMMh8_q4ZMutC0dG7AWDmu2CmlFQ8VhGQR2yl334MvxgaBVEWdPcrTOyJBOkqRVD9mQbzt0z-zwYsngv0LsLyIx7_wzmqDPl7nLy2X_f-Zzdo4aTMsFPTthhu7ozLxDwtPkpG3z6kpy6NP8NhVQCSA
link.rule.ids 230,315,730,783,787,888,27936,27937,53804,53806
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3LbtQwFLVKWcAGAeUxLQ8jIVZ48rLzYIOqGUpamqFSO1J3keM4IqJxRjPpYn6Jb-Ab-Cbu9SQjBnYsIkWJ89L14xz75FxC3vohgPqK-yzwS8G4kJIlMAoxHYQl2m8lWuKKbjYL0zk_uxbXe0QM_8JY0b4q6rG5acam_ma1lYtGOYNOzLnIJiGwiChMnDvkLrRXlw8kve-AI9cm2gXCBcyIR7z_MRgol3M2Q4Hc5eR07AMvZJ5AcRemMfIjD53Sgt3h6R_M-bd08o-x6OQhedCDSHq8edlHZE-bx-Tg2ACBbtb0HbWyTjtffkB-TIEWN4Al6dRjN_V3TQEp6gUm2YE9m4heU0zbaTUD0Pe9p79-sq-Luq3LbVGW2YweGo_0yllD24rOV5pN-zS6Hb1cGwk9kKIXAMlRrd2taW3oFB4Fb5u2S0OtF4hZfaBZu9Q0lcuG4tw9_dy25ccnZH7y6WqSsj5BA1Pc4x3TVayEBEiHWxShmXzhFUqpRKvYcyuRFFyIWCl02avK0otloBNcWtVJESdR8JTsm9bo54S6YSVkFBdVBQitdAsJOEhWMgYAFopABSPiDHHJFxsfjhz5CwQ13wY1x6DCsRyDOiJvhvDl0GRwHUQa3d6ucjQl46iq5SPybBPO7T2HejAi0U6gtwXQjnv3DNRSa8vd18rD_77yNbmXXmXn-fnp7MsRuY8fgToFL35B9rvlrX4J8KcrXtnK_hsnawSp
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3LjtMwFLVgkBAbBAyP8jQSYoWbp_Ngg0YNpTPQUmmoNLvIcWwRMXGiNrPoL_ENfAPfxL1uUk1hx6JSlEeT6Dr2OfHJOYS88SMA9Tr0WeCXnIVcCJbCKMRUEJVov5UqgTO680U0W4VnF_ziWtSXFe3Lohqby3psqu9WW9nW0hl0Ys5yPomARcRR6rSldm6SW_DMutFA1PtOOHZt2C6QLmBHYRz2HwcD7XLOFiiSO5-cjn3ghszjKPDCKCM_9tAtLTgcov7BnX_LJ6-NR9N75G4PJOnJ7oLvkxvKPCDHJwZIdL2lb6mVdtp35sfkZwbUuAY8STOPXVY_FAW0qFoM2oElG0avKEZ3Wt0A9H_v6O9f7GtbNVW535XNbaqHwjW9etbQRtPVRrGsj9Lt6PnWCOiFJF0CLEfFdrellaEZnAqudtasDbV-IGbzns6btaIzsa4pvr-nn5qm_PCQrKYfv01mrA9pYDL0wo4pnUguANbhL47RUL7wCillqmTiuZqnRch5IiU67emy9BIRqBSnV1VaJGkcPCJHpjHqCaFupLmIk0JrQGmlWwjAQkKLBEBYxAMZjIgz1CVvd14cOXIYKGq-L2qORYV1ORZ1RF4P5cvhscG5EGFUc7XJ0ZgsRGVtOCKPd-Xc_-fQDkYkPij0fge05D7cAi3VWnP3LfPpfx_5itxeZtP8y-ni8zNyB-8BpQpe8pwcdesr9QIQUFe8tG39D95sBbw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Dopamine+D1-like+Receptors+Regulate+Constitutive%2C+%CE%BC-Opioid+Receptor-Mediated+Repression+of+Use-Dependent+Synaptic+Plasticity+in+Dorsal+Horn+Neurons%3A+More+Harm+than+Good%3F&rft.jtitle=The+Journal+of+neuroscience&rft.au=Aira%2C+Zigor&rft.au=Barrenetxea%2C+Teresa&rft.au=Buesa%2C+Itsaso&rft.au=Garc%C3%ADa+del+Ca%C3%B1o%2C+Gontzal&rft.date=2016-05-18&rft.pub=Society+for+Neuroscience&rft.issn=0270-6474&rft.eissn=1529-2401&rft.volume=36&rft.issue=20&rft.spage=5661&rft.epage=5673&rft_id=info:doi/10.1523%2FJNEUROSCI.2469-15.2016&rft_id=info%3Apmid%2F27194343&rft.externalDBID=PMC6601769
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0270-6474&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0270-6474&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0270-6474&client=summon